Healthcare 2040: The Future of Chronic Pulmonary Care

What will healthcare look like in 20 years? What should we invest in today to help us get there?

MATTER and Baxter present Healthcare 2040, an event series that invites industry leaders working in significantly transformative areas of healthcare to help us explore these questions.

Leading up to National Chronic Obstructive Pulmonary Disease (COPD) Awareness Month, join us for a critical discussion on the future of chronic pulmonary care. Chronic pulmonary conditions include COPD, pulmonary fibrosis, asthma and more. The prevalence of these conditions is increasing — for instance, in 2019, COPD was the third leading cause of death worldwide, causing 3.23 million deaths. In recent years, chronic pulmonary conditions have been further compounded by the onset of the COVID-19 pandemic and intensifying climate change.

COPD Foundation President and CEO Dr. Ruth Tal-Singer, Baxter Chief Scientist of Respiratory Health Division Tom Westfall and St. Lawrence Health System Pulmonologist and Medical Director of Population Health Dr. Frederic Seifer joined moderator and Baxter Vice President of Medical Affairs Carlos Urrea to discuss the current state of chronic pulmonary conditions and how innovation can shape its future.

For more information, visit matter.health and follow us on social:

LinkedIn @MATTER
Twitter @MATTERhealth
Instagram @matterhealth